NH EPSCoR Speaker Series
NH EPSCoR 2022-2023 Speaker Series
NH EPSCoR is launching a free, virtual, statewide, research-focused speaker series. Each session will feature a topical research theme presented by both an industry and academic research leader sharing their perspectives on the current state, future directions, career paths and opportunities. Each session will be one hour with brief presentations followed by moderated panel discussion and Q&A. Open to all higher ed community members (faculty, staff and students) across the state.
Questions? Please contact Justine Stadler (justine.stadler(at)unh.edu)
UNEARTHING THE GENOME AND THE MAMMOTH
Join Dr. Alexander Titus, VP of Strategy at Colossal Biosciences and Dr. Kelley Thomas, Director of the Hubbard Center for Genome Studies for a discussion on how genomic engineering and ancient DNA may make it possible to de-extinct lost species including the Woolly Mammoth. Could a resurgence of the mammoth slow the melting of the Arctic permafrost and help stabilize our climate?
Opportunities for metal-organic frameworks in chronic kidney disease interventions
Dr. Ian Welsford from Nephria Bio and Dr. Katherine Mirica from the Mirica Group at Dartmouth will discuss the challenges and opportunities inherent in the development of bio-artificial kidney functions and the potential role of Metal Organic Frameworks in this complex endeavor.
ANTIBODY PRODUCT QUALITY ANALYSIS: A UNH/LONZA COLLABORATION ON NOVEL MASS SPECTROMETRY APPROACHES
Join Dr. Nancy Fernandes, Analytical Scientist at Lonza, and Dr. Anyin Li, Assistant Professor of Chemistry at UNH, for a discussion of their collaboration on a novel approach to mass spectrometry. Their research builds on John Fenn’s Nobel Prize winning work on soft electrospray ionization methods for the identification and structure analyses of biological macromolecules. The novel method under development will improve sensitivity and reduce timelines of critical quality attribute analysis of monoclonal antibodies under development at Lonza.
RESEARCH TO MARKET: BIOSENSING BREAKTHROUGH IN WOMEN’S HEALTH
Join Nanopath founders, Dr. Alison Burklund and Dr. Amogha Tadimety, to learn about their path from research students to entrepreneurs. Dr. Burklund and Dr. Tadimety participated in the same PhD innovation fellowship at Thayer School of Engineering at Dartmouth College focused on the development of novel molecular testing platforms which resulted in a biosensing breakthrough in women’s health and the creation of Nanopath in Cambridge, MA. Join us to learn about their innovative diagnostic approach to sensitively and specifically detect viral, bacterial, and fungal pathogens without the need for nucleic acid amplification and their experience building a start-up company.
View Talk: Research to Market: Biosensing Breakthrough in Women’s Health - UNH Media